Company Profile

Ora, Inc. has grown into the world’s leading ophthalmic CRO because of our unequaled ability to accelerate development timelines.


45 product approvals
including the last two NDAs for Bepreve and Lastacaft
Stuart Abelson

Stuart B. Abelson, MBA
President, Chief Executive Officer
David Hollander, MD, MBA

David Hollander, MD, MBA
Sr. Vice President,
Chief Medical Officer
Donna Welch, RN, BSN

Donna Welch, RN, BSN
Sr. Vice President,
Chief Operating Officer

Unequaled Ophthalmic Experience – 40 years, 45 product approvals

Ora is the world’s leading full-service ophthalmic CRO and product development firm with offices in the United States, the United Kingdom and Japan. Over the past 30 years, we helped our clients earn 45 product approvals. We support a wide array of organizations, from start-ups to global pharmaceutical and device companies, to efficiently bring their new products from concept to market. Ora’s pre-clinical and clinical models, unique methodologies and regulatory strategies have been refined and proven across thousands of projects. We bring together the world’s most extensive and experienced team of ophthalmic experts and R&D professionals to maximize the value of new product initiatives.

Our clinical study project management services include:

Our preclinical development services include:

  • Study design
  • Study execution
  • CMC